# Ata Postop Pituitary Apoplexy Monitoring

> Recommends that clinicians monitor pituitary axes in pituitary apoplexy patients treated with surgical decompression or conservative management because hypopituitarism may develop over time. Use when managing pituitary apoplexy patient; triggers include pituitary apoplexy patient needing longitudinal monitoring.

- Skill: `dromlakhani/ata-postop-pituitary-apoplexy-monitoring` (Agent Skill)
- Install (CLI): `npx skillmds@latest add dromlakhani/ata-postop-pituitary-apoplexy-monitoring`
- Raw SKILL.md: https://api.skillmd.com/api/skills/dromlakhani/ata-postop-pituitary-apoplexy-monitoring/raw
- Safety review: pending (external: skill-scanner PASS, skillspector PASS)
- Works with: Claude Code, Claude.ai, OpenAI Codex
- Category: Coding & Dev Tools
- Author: dromlakhani (https://skillmd.com/u/dromlakhani)
- Updated: 2026-09-08
- Page: https://skillmd.com/skills/dromlakhani/ata-postop-pituitary-apoplexy-monitoring

---


# Monitor pituitary axes in pituitary apoplexy patients treated with surgical decompression or conservative management

## STEP 1 — Gather Information
Collect baseline pituitary hormone panel: morning cortisol, TSH with free T4, gonadotropins (LH/FSH) with sex steroids (estradiol/testosterone), IGF-1, prolactin; assess for symptoms of hypopituitarism (fatigue, hypotension, hypoglycemia, menstrual changes, decreased libido); review imaging for residual lesion.

## STEP 2 — Rule In / Rule Out
Test for new pituitary insufficiency: if any hormone falls below age‑appropriate reference limits or symptomatic deficits appear → Rule In deficiency; if all axes remain normal and asymptomatic → Rule Out new deficiency and continue routine surveillance.

## STEP 3 — Classify or Stratify
Classify by number and type of deficient axes: single‑axis (e.g., isolated central adrenal insufficiency) vs multi‑axis (two or more deficiencies); note presence of central diabetes insipidus if polyuria with elevated serum osmolality.

## STEP 4 — Decide
If deficiency confirmed → initiate appropriate hormone replacement (glucocorticoid, levothyroxine, sex steroids, GH, or desmopressin as indicated) and schedule repeat testing in 6–12 weeks; if no deficiency → repeat full pituitary panel at 6‑month intervals or sooner if symptoms evolve.

## Clinical Guardrails / Mimics / Pitfalls
Do not rely on symptoms alone; asymptomatic hypopituitarism is common. Do not delay glucocorticoid replacement if adrenal insufficiency is suspected due to mortality risk. Avoid assuming postoperative recovery; hypopituitarism can emerge months later. Do not mistake central DI for primary polydipsia without water deprivation test. Do not overlook masked deficiencies due to estrogen‑induced CBG elevation affecting cortisol interpretation.

## Concrete Clinical Example
A 58‑year‑old woman undergoes endoscopic resection for pituitary apoplexy. At 3‑month follow‑up she reports fatigue and mild hypotension. Morning cortisol is 8 µg/dL (low), TSH 0.8 mIU/L with free T4 0.7 ng/dL (low‑normal), IGF‑1 low, LH/FSH low with low estradiol. She is diagnosed with central adrenal insufficiency, central hypothyroidism, and hypogonadism; hydrocortisone 15 mg daily, levothyroxine 100 µg daily, and transdermal estradiol are started, with repeat testing planned in 8 weeks.

**Source:** Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, https://doi.org/10.1210/jc.2016-2118